Dyne Therapeutics
168 hedge funds and large institutions have $2.71B invested in Dyne Therapeutics in 2024 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 69 increasing their positions, 27 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
35% more funds holding
Funds holding: 124 → 168 (+44)
0.84% less ownership
Funds ownership: 117.21% → 116.37% (-0.84%)
57% less call options, than puts
Call options by funds: $4.68M | Put options by funds: $10.8M
Holders
168
Holding in Top 10
10
Calls
$4.68M
Puts
$10.8M
Top Buyers
| 1 | +$141M | |
| 2 | +$87.8M | |
| 3 | +$75.6M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$72.5M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$66M |
Top Sellers
| 1 | -$87.5M | |
| 2 | -$53M | |
| 3 | -$47.3M | |
| 4 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$42.6M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$36M |